Products

MOZI TPS
Manteia Technologies Co., Ltd.
Oncology AI
Mozi is the next-generation treatment planning solution, combining precision, speed, and adaptability. With built-in patient-specific goals, real-time adaptive planning, and intelligent automated planning, Mozi streamlines your workflow and evolves with future innovation.
ARTAssistant
Manteia Technologies Co., Ltd.
Oncology AI
ARTAssistant by Manteia Technologies Co., Ltd. is an FDA-cleared AI-powered software for adaptive radiation therapy, focusing on image processing, registration, and contouring to enhance precision and efficiency in cancer treatment.
AccuContour
Manteia Technologies Co., Ltd.
Oncology AI
AccuContour by Manteia Technologies is an AI-driven auto-contouring solution for radiation oncology, enhancing efficiency and precision in treatment planning through automated OAR and tumor target contouring, image fusion, plan review, and dose accumulation.

See all 3 products →

About Manteia Technologies Co.

Manteia Technologies Co. is a healthcare AI company dedicated to advancing precision radiotherapy and optimizing clinical workflows through the application of artificial intelligence, big data, and advanced algorithmic technologies. Their solutions are designed to enhance the safety, accuracy, and efficiency of cancer treatment.

The company offers a comprehensive suite of vendor-independent radiation therapy software. Key products include AccuContour™, an AI-powered auto-contouring and image processing solution for delineating organs-at-risk and tumors; Mozi TPS, a next-generation treatment planning system that incorporates AI-driven auto-planning and high-performance GPU-based Monte Carlo dose calculation; and AccuCheck, a quality assurance software for data transfer integrity, secondary dose calculation, and treatment plan verification. Manteia also provides AccuLearning®, a deep learning platform for training custom AI segmentation models. These tools aim to streamline various stages of the radiation oncology workflow, from initial image registration and contouring to treatment planning, quality assurance, and adaptive radiotherapy.

Focus Areas

Precision radiotherapy adaptive radiotherapy radiation oncology software AI-based auto-contouring treatment planning QA/QC medical imaging deep learning Monte Carlo algorithms

Business Intelligence

Key InvestorsFosun, Deyi Capital
PartnershipsKlarity Medical, Tema Sinergie, PTW Freiburg, New York Proton Center (client testimonial)
TechnologyAI, deep learning, big data, advanced algorithms, Monte Carlo algorithms, cloud-native (implied), local servers, vendor-independent, GPU-powered computation
FDA Clearances4 cleared products (estimated)

What Physicians Need to Know

Precision Radiotherapy
Manteia Technologies offers comprehensive solutions for precision radiation therapy, integrating advanced AI and Monte Carlo algorithms to ensure highly accurate and targeted treatments.
Adaptive Radiotherapy (ART)
Specializes in adaptive radiation therapy with their Mozi TPS, which features revolutionary on-line adaptive planning for real-time adjustments to anatomical changes, enabling truly personalized care.
AI-based Auto-Contouring
AccuContour provides AI-driven auto-contouring for organs-at-risk (OARs), lymph nodes, and tumor targets, significantly boosting efficiency by completing contours in approximately one minute per patient.
Advanced Treatment Planning
Mozi TPS is a next-generation treatment planning system that optimizes various techniques including 3DCRT, IMRT, VMAT, and SBRT, with a strong commitment to automation and intelligent planning.
Comprehensive QA/QC
Their QA Solution, integrating AccuCheck and QA Pro, offers automated and intelligent quality assurance through Monte Carlo-based secondary dose calculations, log file dose reconstruction, machine QA workflow automation, and predictive maintenance.
Medical Imaging & Registration
Supports advanced fusion and registration for multi-modality images including CT, MRI, PET-CT, and 4D, ensuring accurate alignment for precise treatment planning.
Deep Learning & Monte Carlo Algorithms
Leverages deep learning for auto-contouring (AccuContour, AccuLearning) and automatic contouring in Mozi TPS, alongside Monte Carlo algorithms for gold-standard dose calculation and high-precision QA.
Physician Tip

For physicians, Manteia Technologies Co. stands out by offering solutions that significantly enhance efficiency and precision in radiation oncology. Their AI-based auto-contouring (AccuContour) can save hundreds of hours for planners, allowing physicians more time to focus on complex cases and patient interaction. The integration of Monte Carlo algorithms ensures highly accurate dose calculations, leading to more precise treatment plans and potentially improved patient outcomes. Furthermore, their revolutionary on-line adaptive radiotherapy capabilities (Mozi TPS) enable real-time adjustments, providing truly personalized and effective cancer treatment. The vendor-independent nature of their software ensures seamless integration with existing clinic workflows and equipment, minimizing disruption. The ability to train custom AI models with AccuLearning allows for tailored solutions that align with specific clinical protocols and patient populations, offering a high degree of customization and control. Finally, the FDA approval of Mozi TPS provides an assurance of safety and effectiveness.

Manteia Technologies Co. emphasizes vendor-independence and full interoperability. Their systems are designed to seamlessly integrate into existing radiation oncology workflows, supporting various treatment machines, linear accelerators (linacs), and QA devices. This ensures compatibility with diverse RT environments without requiring a complete overhaul of current infrastructure.

Products by Manteia Technologies Co.

3 products in the directory

MOZI TPS
Manteia Technologies Co., Ltd.
Oncology AI
Mozi is the next-generation treatment planning solution, combining precision, speed, and adaptability. With built-in patient-specific goals, real-time adaptive planning, and intelligent automated planning, Mozi streamlines your workflow and evolves with future innovation.
ARTAssistant
Manteia Technologies Co., Ltd.
Oncology AI
ARTAssistant by Manteia Technologies Co., Ltd. is an FDA-cleared AI-powered software for adaptive radiation therapy, focusing on image processing, registration, and contouring to enhance precision and efficiency in cancer treatment.
AccuContour
Manteia Technologies Co., Ltd.
Oncology AI
AccuContour by Manteia Technologies is an AI-driven auto-contouring solution for radiation oncology, enhancing efficiency and precision in treatment planning through automated OAR and tumor target contouring, image fusion, plan review, and dose accumulation.

Reviews & Opinions

No web reviews on file yet for Manteia Technologies Co.. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Manteia Technologies Co..

Loading videos...

Videos load interactively. If none appear, search YouTube for Manteia Technologies Co. →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Manteia Technologies offers a comprehensive suite of radiation oncology software, including AccuContour for AI auto-contouring, Mozi TPS for treatment planning, AccuLearning for deep learning model training, and a QA Solution integrating AccuCheck and QA Pro. These solutions are designed to be vendor-independent and integrate AI and Monte Carlo algorithms to enhance precision, efficiency, and automation in image-based treatment planning, quality assurance, and Adaptive Radiation Therapy (ART). Mozi TPS, in particular, enables seamless end-to-end on-line adaptive RT workflows.
Manteia's AccuContour utilizes deep learning models for AI auto-contouring, demonstrating high efficiency and validated performance in over 1,200 clinical centers worldwide. For dose calculation, their Mozi TPS and AccuCheck products incorporate GPU-powered Monte Carlo dose engines, which are considered the 'gold standard' for accuracy in complex cases and are backed by robust research. The integration of AI with Monte Carlo methods aims to achieve both speed and accuracy in dose estimation.
Manteia Technologies Co. has obtained FDA 510(k) clearances for its AccuCheck QA software and Mozi TPS, indicating that these devices are substantially equivalent to legally marketed predicate devices for their intended uses. The company adheres to general regulatory controls, including requirements for registration, device listing, labeling, and good manufacturing practices.
Manteia Technologies emphasizes vendor independence, designing its software to be fully interoperable and seamlessly integrate into existing radiation oncology workflows. Their Mozi TPS supports various accelerator types, allowing a single treatment planning system to work with different hardware. AccuContour is also designed for full compatibility, connecting with all RT systems.
Manteia offers a comprehensive QA Solution that integrates AccuCheck and QA Pro. AccuCheck provides high-precision 3D dose verification through Monte Carlo-based secondary dose calculations and log file dose reconstruction for accurate, independent treatment plan validation. QA Pro streamlines machine QA workflows by automating task scheduling, data collection, trend analysis, and predictive maintenance.
Yes, Manteia's AI solutions offer customization capabilities. AccuContour supports the use of self-trained models for AI auto-contouring, allowing clinics to adapt the software to their specific needs. Additionally, AccuLearning is a dedicated deep learning platform that enables users to train standard models using their own datasets, facilitating the creation of custom contour models and supporting personalized protocols.
Manteia Technologies collaborates with strategic partners, such as Tema Sinergie, for business development and customer support across regions like EMEA. These partnerships involve identifying local distributors and providing comprehensive technical and commercial support for both pre-sales and post-sales activities. The company's website also provides direct contact information for inquiries and support.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.